日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.

BCL-xL 作为西妥昔单抗耐药性结直肠癌的治疗靶点。

Asmanidou Stella, Thiel Julia, Ekstrom Thomas L, Schueler Julia, Oswald Eva, Metzger Patrick, Blaumeiser Andreas C, Boerries Melanie, Wiebl Lisa-Marie, Schiffler Ronja, Tamas Raluca, Essmann Frank, Dong Meng, Johnsen Steven A, Kontermann Roland E, Olayioye Monilola A

The making of multispecific immunoglobulins - a clinical perspective

多特异性免疫球蛋白的制备——临床视角

Brinkmann, Ulrich; Kontermann, Roland E

Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR

编码双特异性T细胞衔接器或新型三特异性T细胞衔接器的溶瘤腺病毒,可双重靶向c-MET和EGFR。

Boos, Martin A; Seifert, Oliver; Sawall, Stefanie; Genz, Jessica; Huber, Annika; Hofmann, Ilse; Kontermann, Roland E; Ungerechts, Guy; Nettelbeck, Dirk M

Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3.

靶向 HER2 和 HER3 的三特异性 eFab-eIg T 细胞衔接器

Löffler Ann-Kathrin, Huber Annika, Olayioye Monilola A, Kontermann Roland E, Seifert Oliver

Single intracerebroventricular TNFR2 agonist injection impacts remyelination in the cuprizone model

单次脑室内注射TNFR2激动剂可影响铜嗪模型中的髓鞘再生

Pegoretti, Valentina; Boerema, Ate; Kats, Kim; Dafauce Garcia, Juan M; Fischer, Roman; Kontermann, Roland E; Pfizenmaier, Klaus; Laman, Jon D; Eisel, Ulrich L M; Baron, Wia

Comparison of antibody-scTRAIL Fc fusion proteins with varying valency for EGFR and TRAIL receptors.

比较不同价态的抗体-scTRAIL Fc融合蛋白对EGFR和TRAIL受体的结合情况

Michler Dennis, Seifert Oliver, Pfizenmaier Klaus, Kontermann Roland E

Comparative Assessment of Various Formats of TRAIL in Three-Dimensional Cell Culture and Patient-Derived Tumoroids of Colorectal Cancer

TRAIL技术在三维细胞培养和结直肠癌患者来源类瘤中的不同形式的比较评估

Vafaeinik, Farzaneh; Helmueller, Sarah; Gangi, Alexandra; Ku, Ja-Lok; Kontermann, Roland; Lee, Yong J

Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis

肿瘤坏死因子受体 2 激活对多发性硬化症模型中的皮质髓鞘蛋白和功能恢复产生性别特异性影响

Kayla L Nguyen, Ishaan J Bhatt, Shruti Gupta, Nazaf Showkat, Kathryn A Swanson, Roman Fischer, Roland E Kontermann, Klaus Pfizenmaier, Valerie Bracchi-Ricard, John R Bethea

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS

使用 TNFR2 激动剂和 TNFR1 拮抗剂进行序贯治疗可改善人源化小鼠 MS 模型的疗效

Valentina Pegoretti, Jan Bauer, Roman Fischer, Iskra Paro, Wanda Douwenga, Roland E Kontermann, Klaus Pfizenmaier, Evelien Houben, Bieke Broux, Niels Hellings, Wia Baron, Jon D Laman, Ulrich L M Eisel

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis

在多发性硬化症动物模型中 TNFR1 和 TNFR2 的协同调节

Timon Fiedler # ,Richard Fairless # ,Kira Pichi ,Roman Fischer ,Fabian Richter ,Roland E Kontermann ,Klaus Pfizenmaier ,Ricarda Diem ,Sarah K Williams